Lauren P Daskivich1, Carolina Vasquez2, Carlos Martinez3, Chi-Hong Tseng2, Carol M Mangione4. 1. Ophthalmology and Eye Health Programs, Department of Health Services, Los Angeles County, Los Angeles, California. 2. Department of Medicine, David Geffen School of Medicine, UCLA (University of California, Los Angeles)3Department of Health Policy and Management, UCLA Fielding School of Public Health, University of California, Los Angeles. 3. Charles R. Drew University of Medicine and Science, Los Angeles, California. 4. Department of Medicine, David Geffen School of Medicine, UCLA (University of California, Los Angeles).
Abstract
Importance: Diabetic retinopathy (DR) is the leading cause of blindness in adults of working age in the United States. In the Los Angeles County safety net, a nonvertically integrated system serving underinsured and uninsured patients, the prevalence of DR is approximately 50%, and owing to limited specialty care resources, the average wait times for screening for DR have been 8 months or more. Objective: To determine whether a primary care-based teleretinal DR screening (TDRS) program reduces wait times for screening and improves timeliness of needed care in the Los Angeles County safety net. Design, Setting, and Participants: Quasi-experimental, pretest-posttest evaluation of exposure to primary care-based TDRS at 5 of 15 Los Angeles County Department of Health Services safety net clinics from September 1, 2013, to December 31, 2015, with a subgroup analysis of random samples of 600 patients before and after the intervention (1200 total). Exposure: Primary care clinic-based teleretinal screening for DR. Main Outcomes and Measures: Annual rates of screening for DR before and after implementation of the TDRS program across the 5 clinics, time to screening for DR in a random sample of patients from these clinics, and a description of the larger framework of program implementation. Results: Among the 21 222 patients who underwent the screening (12 790 female, 8084 male, and 348 other gender or not specified; mean [SD] age, 57.4 [9.6] years), the median time to screening for DR decreased from 158 days (interquartile range, 68-324 days) before the intervention to 17 days (interquartile range, 8-50 days) after initiation of the program (P < .001). Overall annual screening rates for DR increased from 5942 of 14 633 patients (40.6%) before implementation to 7470 of 13 133 patients (56.9%) after initiation of the program at all 15 targeted clinics (odds ratio, 1.9; 95% CI, 1.3-2.9; P = .002). Of the 21 222 patients who were screened, 14 595 (68.8%) did not require referral to an eye care professional, 4160 (19.6%) were referred for treatment or monitoring of DR, and 2461 (11.6%) were referred for other ophthalmologic conditions. Conclusions and Relevance: A digital TDRS program was successfully implemented for the largest publicly operated county safety net population in the United States, resulting in the elimination of the need for more than 14 000 visits to specialty care professionals, a 16.3% increase in annual rates of screening for DR, and an 89.2% reduction in wait times for screening. Teleretinal DR screening programs have the potential to maximize access and efficiency in the safety net, where the need for such programs is most critical.
Importance: Diabetic retinopathy (DR) is the leading cause of blindness in adults of working age in the United States. In the Los Angeles County safety net, a nonvertically integrated system serving underinsured and uninsured patients, the prevalence of DR is approximately 50%, and owing to limited specialty care resources, the average wait times for screening for DR have been 8 months or more. Objective: To determine whether a primary care-based teleretinal DR screening (TDRS) program reduces wait times for screening and improves timeliness of needed care in the Los Angeles County safety net. Design, Setting, and Participants: Quasi-experimental, pretest-posttest evaluation of exposure to primary care-based TDRS at 5 of 15 Los Angeles County Department of Health Services safety net clinics from September 1, 2013, to December 31, 2015, with a subgroup analysis of random samples of 600 patients before and after the intervention (1200 total). Exposure: Primary care clinic-based teleretinal screening for DR. Main Outcomes and Measures: Annual rates of screening for DR before and after implementation of the TDRS program across the 5 clinics, time to screening for DR in a random sample of patients from these clinics, and a description of the larger framework of program implementation. Results: Among the 21 222 patients who underwent the screening (12 790 female, 8084 male, and 348 other gender or not specified; mean [SD] age, 57.4 [9.6] years), the median time to screening for DR decreased from 158 days (interquartile range, 68-324 days) before the intervention to 17 days (interquartile range, 8-50 days) after initiation of the program (P < .001). Overall annual screening rates for DR increased from 5942 of 14 633 patients (40.6%) before implementation to 7470 of 13 133 patients (56.9%) after initiation of the program at all 15 targeted clinics (odds ratio, 1.9; 95% CI, 1.3-2.9; P = .002). Of the 21 222 patients who were screened, 14 595 (68.8%) did not require referral to an eye care professional, 4160 (19.6%) were referred for treatment or monitoring of DR, and 2461 (11.6%) were referred for other ophthalmologic conditions. Conclusions and Relevance: A digital TDRS program was successfully implemented for the largest publicly operated county safety net population in the United States, resulting in the elimination of the need for more than 14 000 visits to specialty care professionals, a 16.3% increase in annual rates of screening for DR, and an 89.2% reduction in wait times for screening. Teleretinal DR screening programs have the potential to maximize access and efficiency in the safety net, where the need for such programs is most critical.
Authors: Anthony A Cavallerano; Jerry D Cavallerano; Paula Katalinic; Ann Marie Tolson; Lloyd Paul Aiello; Lloyd M Aiello Journal: Retina Date: 2003-04 Impact factor: 4.256
Authors: Sharat P Iyer; Andrea Jones; Efrain Talamantes; Elizabeth S Barnert; Hemal K Kanzaria; Alissa Detz; Timothy J Daskivich; Loretta Jones; Gery W Ryan; Anish P Mahajan Journal: Ethn Dis Date: 2015-11-05 Impact factor: 1.847
Authors: Spencer D Fuller; Jenny Hu; James C Liu; Ella Gibson; Martin Gregory; Jessica Kuo; Rithwick Rajagopal Journal: J Diabetes Sci Technol Date: 2020-10-30
Authors: Daniella Meeker; Paul Fu; Gary Garcia; Irene E Dyer; Kabir Yadav; Ross Fleishman; Hal F Yee Journal: J Am Med Inform Assoc Date: 2022-03-15 Impact factor: 4.497
Authors: Christina Mehranbod; Pauline Genter; Lilian Serpas; Johana Macias; David Campa; David Bermon; Eli Ipp Journal: J Med Syst Date: 2019-12-09 Impact factor: 4.460
Authors: Sang Jin Kim; J Peter Campbell; Jayashree Kalpathy-Cramer; Susan Ostmo; Karyn E Jonas; Dongseok Choi; R V Paul Chan; Michael F Chiang Journal: JAMA Ophthalmol Date: 2018-06-01 Impact factor: 7.389
Authors: William S Gange; Jennifer Lopez; Benjamin Y Xu; Khristina Lung; Seth A Seabury; Brian C Toy Journal: Diabetes Care Date: 2021-09-02 Impact factor: 19.112